Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
* Glaxo had sought $571 million, was awarded $3.5 mln * Abbott excluded juror because of sexual orientation * Ruling shows influence of recent Supreme Court opinion By Dan Levine SAN FRANCISCO, Jan 21 (Reuters) - A gay man was improperly excluded from jury service because
21 Jan 14 21:10By Dan Levine SAN FRANCISCO, Jan 21 (Reuters) - GlaxoSmithKline Plc deserves a new trial against Abbott Laboratories because Abbott impermissibly excluded a potential juror based on his sexual orientation, a federal appeals court ruled on Tuesday. The case involved Abbott's pricing
21 Jan 14 18:31SAN FRANCISCO, Jan 21 (Reuters) - GlaxoSmithKline Plc deserves a new trial against Abbott Laboratories because Abbott impermissibly excluded a potential juror based on his sexual orientation, a federal appeals court ruled on Tuesday. GSK had won a jury verdict for about $3.5 million again
21 Jan 14 17:35- FTSE 100 fails to break 2013 intraday high - Credit squeeze eases in China - IMF lifts global growth forecasts techMARK 2,846.40 -0.25% FTSE 100 6,834.26 -0.04% FTSE 250 16,144.20 -0.51% After a choppy session, UK markets finished broadly flat on Tuesday as the FTSE 100 teetered at levels not re
21 Jan 14 16:38Drugs maker GlaxoSmithKline rose after reporting that its new HIV treatment, Tivicay, has received approval in Europe. The drug is manufactured by ViiV Healthcare, a company in which GSK, Pfizer and Shionogi are shareholders. Tivicay is for use in combination with other anti-retroviral medicinal
21 Jan 14 15:23Intertek, a provider of testing and safety solutions, jumped as a result of readacross from its sector peer, Swiss firm SGS, which posted upbeat full-year results. Consumer products group Unilever was also high riser today after reporting underlying sales growth of 4.3% for 2013, helped by strong
21 Jan 14 15:09(An item published at 1259 GMT misstated the market prices. The correct version follows.) LONDON (Alliance News) - Anglo-Dutch consumer goods and food giant<strong> Unilever</strong> Tuesday kicked off the latest UK earnings season, reporting lower revenues for the fourth quarter and who
21 Jan 14 13:03LONDON (Alliance News) - Anglo-Dutch consumer goods and food giant<strong> Unilever</strong> Tuesday kicked off the latest UK earnings season, reporting lower revenues for the fourth quarter and whole of 2013, but its earnings beat expectations as margins were supported by price increases and
21 Jan 14 12:59LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday that its joint venture Viiv Healthcare Ltd saw its Tivicay integrase inhibitor approved for use in combination with other anti-retroviral medicinal products for the treatment of HIV by the European Commission. This regulation authori
21 Jan 14 12:01LONDON (Alliance News) - Healthcare and pharmaceuticals giant GlaxoSmithKline PLC Monday said that Executive Director Moncef Slaoui was allocated 15 American Depositary Shares at a price of USD54.10 each on January 17. Glaxo shares closed at 1,657.68 pence per share Monday, up 0.8%. B
20 Jan 14 17:41LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning and Friday afternoon:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />CREDIT SUISSE RAISES NEXT PRICE TARGET TO 6500 (5500) PENCE - 'NEUTRAL' <br />----------<br />BERENBERG RAI
20 Jan 14 10:05Credit Suisse predicts major European drugmakers will report 4 percent sales growth and 6 percent earnings per shares (EPS) growth this year, with companies such as Bayer and Novartis seen outperforming the market. It expects that Roche will also do well. "EU Pharma benefitted from a
20 Jan 14 09:35LONDON (Alliance News) - GlaxoSmithKline PLC Friday said Deidre Connelly, divisional president and Bill Louv, divisional senior vice president bought American Depositary shares following the re-investment of dividends January 9.<br /><br />Details are as follows. <table class="
17 Jan 14 17:08(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stocks fell on Thursday, with the S&P 500 pulling back from record levels following a round
16 Jan 14 20:00(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stocks fell on Thursday, with the S&P 500 pulling back from record levels following a round
16 Jan 14 18:26
Last checked at